Dr. Joel Pachter, Professor of Cell Biology at the University of Connecticut Health Center discusses how he was able to genetically profile micro-vessels to monitor changes during the progression of inflammatory diseases such as Multiple Sclerosis.

Take a look at how Dr. Pachter used the Life Technologies laser capture microdissection (LCM)/qPCR workflow to get a better understanding of how to begin to develop pharmacatherapies to address diseases associated with the blood brain barrier.